Development
Many individuals and organisations contribute towards the preparation of the BNF. It is authored by Pharmaceutical Press, the Royal Pharmaceutical Society's (RPS) knowledge business; and is jointly published by the BMJ (owned by the BMA), and Pharmaceutical Press (owned by the RPS). It is published under the authority of a Joint Formulary Committee (JFC), which comprises pharmacy, medical, nursing, and lay representatives; there are also representatives from the Medicines and Healthcare products Regulatory Agency (MHRA), the UK Health Departments, and a national guideline producer. Information on drugs is drawn from the manufacturers' product literature, medical and pharmaceutical literature, regulatory authorities and professional bodies. Advice is constructed from clinical literature, and reflects, as far as possible, an evaluation of the evidence from diverse sources. The BNF also takes account of authoritative national guidelines and emerging safety concerns. In addition, the Joint Formulary Committee takes advice on all therapeutic areas from advisers from expert groups; this ensures that the BNF's recommendations are relevant to practice. In September 2016, the National Institute for Health and Care Excellence (NICE) in the UK gave NICE accreditation to the processes to produce BNF publications; a further review in 2021 resulted in the successful renewal of accreditation.History
It was first published in 1949, as the ''National Formulary'', with updated versions appearing every three years until 1976. The fifth version in 1957 saw its name change to ''The British National Formulary''. A new-look version, under the auspices of Owen Wade, was released in 1981. A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice, while also achieving a cost saving. By 2003, issue 46 of the BNF contained 3000 interactions or groups of interactions, with about 900 of these marked by a bullet.Editions
A new edition of the BNF book is published twice-yearly, in March and September. The current edition is 87, which was published in March 2024. It is a tradition that the colour of each new edition is radically different from the previous.Availability
BNF content is available digitally via a website and mobile app, and as a book. The book is available for purchase. In 2023, NICE announced their decision to stop the supply of print BNF to NHS organisations in England. The same decision was made by Scotland and Wales. NHS workers and healthcare professionals in the HINARI group of developing nations are entitled to free access via MedicinesComplete following registration (requires provision of a name, an address, an email address, and a phone number). Other visitors can subscribe to the BNF on MedicinesComplete. Healthcare organisations can also subscribe to a customisable BNF via their corporate online intranet. In 2017, BNF Publications released applications for offline access to the BNF on iOS and Android devices. Monthly content updates are available, over an internet connection. NICE provides a website providing the content of the BNF for non-commercial to the public, including non-NHS users. The BNF also includes the Nurse Prescribers' Formulary (NPF) and other NPF content for use by District Nurses and Specialist Community Public Health Nurses (including Health Visitors), who have received training to become nurse prescribers.Sister publications
The '' British National Formulary for Children'' (BNFC) British National Formulary for Children book, first published September 2005, is published yearly, and details the doses and uses of medicines in children from neonates to adolescents.BNF sections
The ''British National Formulary'' is divided into various sections; with the main sections on drugs and preparations being organised by body system. ;Table of Contents *Preface *Acknowledgements *How BNF publications are constructed *How to use the BNF *Changes *Guidance on prescribing *Prescription writing *Emergency supply of medicines *Controlled drugs and drug dependence *Adverse reactions to drugs *Guidance on intravenous infusions *Medicines optimisation *Antimicrobial stewardship *Prescribing for children *Prescribing in hepatic impairment *Prescribing in renal impairment *Prescribing in pregnancy *Prescribing in breast-feeding *Prescribing in palliative care *Prescribing for the elderly *Drugs and sport *Prescribing in dental practice ;Notes on drugs and preparations # Gastro-intestinal system # Cardiovascular system # Respiratory system # Nervous system # Infection # Endocrine system # Genito-urinary system # Malignant disease # Blood and nutrition # Musculoskeletal system # Eye # Ear, nose, and oropharynx # Skin # Vaccines # Anaesthesia # Emergency treatment of poisoning ;Appendices and indices *Appendix 1 Interactions *Appendix 2 Borderline substances *Appendix 3 Cautionary and advisory labels for dispensed medicines *Appendix 4 Wound management products and elasticated garments *Dental Practitioners' Formulary *Nurse Prescribers' Formulary *Non-medical prescribing *Index of proprietary manufacturers *Special-order manufacturersSee also
* Pharmacopeia * Specification (technical standard)References
External links
* {{Pharmaceutical and biotechnology industry in the United Kingdom Pharmacy in the United Kingdom Professional associations based in the United Kingdom Medical manuals British books Pharmacology literature